BONE Insider Trading Activity and SEC Form 4 Filings
BONE insider trading summary
No open-market insider purchases or sales of Xtant Medical Holdings, Inc. (BONE) have been reported on SEC Form 4 in the past 12 months.
Latest BONE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 4, 2015 | Jon M. Wickwire | Director | Buy | $40K (10,869 @ $3.68) |
| Sep 4, 2015 | Kent L Swanson | Director | Buy | $110K (30,000 @ $3.68) |
| Sep 4, 2015 | John Arthur Deedrick | Director | Buy | $25K (6,793 @ $3.68) |
| Sep 4, 2015 | Daniel S Goldberger | Chief Executive Officer | Buy | $300K (81,522 @ $3.68) |
| Sep 4, 2015 | Michael A Lopach | Director | Buy | $40K (10,869 @ $3.68) |
| Jun 10, 2014 | Darrel Lee Holmes | COO | Sell | $37K (50,000 @ $0.74) |
| May 22, 2014 | Daniel S Goldberger | President and CEO | Buy | $16K (25,000 @ $0.65) |
| May 20, 2014 | Gregory Alexander Juda | Chief Scientific Officer | Buy | $14K (20,000 @ $0.69) |
| May 7, 2014 | Guy S Cook | 10% Owner | Sell | $330K (500,000 @ $0.66) |
| May 7, 2014 | Guy S Cook | 10% Owner | Sell | $241K (365,000 @ $0.66) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.